OVERVIEW

2026 Pacific Northwest Head & Neck Cancer Symposium is organized by Fred Hutchinson Cancer Center and will be held on Oct 10, 2026 at Fred Hutch Cancer Center, Seattle, Washington, United States of America.

Description:
Advance your clinical practice at the Pacific Northwest Head and Neck Cancer Symposium, an in-person, multidisciplinary educational program hosted at Fred Hutch Cancer Center. This fall symposium will feature expert-led updates on emerging immunotherapy data, radiotherapy innovations, management of thyroid and salivary gland malignancies, and advances in surgical ablation and reconstruction. Designed for healthcare professionals involved in head and neck cancer care, the program emphasizes evidence-based, real-world clinical decision-making.

Learning Objectives:
Upon completion of this activity, learners should be able to:

  1. Explain recently published neoadjuvant and adjuvant immune checkpoint inhibitor trials and illustrate relevant clinical decision-making in selected mucosal and cutaneous squamous cell carcinoma patients. 
  2. Assess updates in the management of salivary gland cancers, including indications for proton and neutron radiotherapy. 
  3. Analyze recently-published studies in the management of well-differentiated and anaplastic thyroid cancers. 
  4. Evaluate innovations in surgical ablation and reconstruction. 
  5. Manage implicit bias in the diagnosis and management of head and neck cancers. 

KEY DATES

Registrations Open
30 Jun, 2026
Registrations Open
Event Start Date
10 Oct, 2026
Event Start Date
Event End Date
10 Oct, 2026
Event End Date
Credits

Credits:
In support of improving patient care, the University of Washington School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Washington School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 7.25 AMA PRA Category 1 Credits™
  • TARGET AUDIENCE

    PhysicianPharmacistOncologistsResidentsNursesAllied Health ProfessionalsFellowsOral and Maxillofacial SurgeonsAdvanced Practice Providers

    SPECIALITIES

    OncologyOral and Maxillofacial Surgery

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationFred Hutch Cancer Center
    1100 Fairview Ave N

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235